Axsome Therapeutics, Inc. (AXSM)
167.55
-3.14
(-1.84%)
USD |
NASDAQ |
Jan 08, 16:00
167.52
-0.04
(-0.02%)
After-Hours: 20:00
Axsome Therapeutics Research and Development Expense (Quarterly): 40.04M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 68.85M |
| Gilead Sciences, Inc. | 1.334B |
| Vanda Pharmaceuticals, Inc. | 22.56M |
| Fortress Biotech, Inc. | 0.208M |
| TG Therapeutics, Inc. | 40.88M |